Publications and communications of Laurence LUTTERI

El Moussaoui, M., Desmecht, S., Lambert, N., Maes, N., Braghini, J., MARECHAL, N., Quintana, C., BRIQUET, K., Gofflot, S., Toussaint, F., Hayette, M.-P., Vermeersch, P., Lutteri, L., GREGOIRE, C., Beguin, Y., Rahmouni, S., Moutschen, M., Desmecht, D., & Darcis, G. (2023). Cluster Analysis Identifies Distinct Patterns of T-Cell and Humoral Immune Responses Evolution Following a Third Dose of SARS-CoV-2 Vaccine in People Living with HIV. Viruses, 15, 1435. doi:10.3390/v15071435

Castiglione, V., Berodes, M., LUKAS, P., Louis, E., Cavalier, E., & Lutteri, L. (27 September 2022). New Faecal Calprotectin Assay by IDS: Validation and Comparison to DiaSorin Method. Diagnostics, 12 (10), 2338. doi:10.3390/diagnostics12102338

El Moussaoui, M., Desmecht, S., Tashkeev, A., Lambert, N., Maes, N., Braghini, J., MARECHAL, N., Quintana, C., BRIQUET, K., Gofflot, S., TOUSSAINT, F., Hayette, M.-P., Vermeersch, P., Lutteri, L., Grégoire, C., Beguin, Y., Rahmouni, S., Moutschen, M., Desmecht, D., & Darcis, G. (05 September 2022). Reduced T-cell response following a third dose of SARS-CoV-2 vaccine in infection-naïve people living with HIV. Journal of Infection, 85, 751-755. doi:10.1016/j.jinf.2022.09.006

Dauby, S., DIVE, D., LUTTERI, L., ANDRIS, C., HANSEN, I., MAQUET, P., & LOMMERS, E. (2022). Comparative study of AQP4‑NMOSD, MOGAD and seronegative NMOSD: a single‑center Belgian cohort. Acta Neurologica Belgica. doi:10.1007/s13760-021-01712-3

Desmecht, S.* , Tashkeev, A.* , El Moussaoui, M., MARECHAL, N., Perée, H., Tokunaga, Y., Fombellida-Lopez, C., Polese, B., Legrand, C., Wéry, M., Mni, M., Fouillien, N., TOUSSAINT, F., Gillet, L., Bureau, F., LUTTERI, L., HAYETTE, M.-P., MOUTSCHEN, M., MEURIS, C., ... DARCIS, G.*. (2022). Kinetics and persistence of the cellular and humoral immune responses to BNT162b2 mRNA vaccine in SARS-CoV-2-naive and -experienced subjects: impact of booster dose and breakthrough infections. Frontiers in Immunology, 13, 863554. doi:10.3389/fimmu.2022.863554
* These authors have contributed equally to this work.

HUART, J., BOUQUEGNEAU, A., Lutteri, L., ERPICUM, P., GROSCH, S., Résimont, G., WIESEN, P., BOVY, C., Krzesinski, J.-M., THYS, M., LAMBERMONT, B., Misset, B., Pottel, H., Mariat, C., CAVALIER, E., Burtey, S., Jouret, F., & DELANAYE, P. (23 January 2021). Proteinuria in COVID‑19: prevalence, characterization and prognostic role. Journal of Nephrology, 34 (3), 355-364. doi:10.1007/s40620-020-00931-w

BOUQUEGNEAU, A., HUART, J., LUTTERI, L., ERPICUM, P., GROSCH, S., Résimont, G., WIESEN, P., ROUSSEAU, A.-F., BOVY, C., KRZESINSKI, J.-M., THYS, M., LAMBERMONT, B., Misset, B., Pottel, H., DARCIS, G., CAVALIER, E., JOURET, F., & DELANAYE, P. (2021). Survivors of COVID-19 mostly recover from tubular proteinuria and acute kidney injury after hospital discharge. Journal of Nephrology, 34 (4), 967-969. doi:10.1007/s40620-021-01075-1

RADERMECKER, A., BONNET, C., LUTTERI, L., CHAPELLE, A.-C., PETIGNOT, S., LIEVENS, I., & CAERS, J. (2021). Un cas illustratif de syndrome de POEMS. Revue Médicale de Liège, 76, 156-159.

Résimont, G., GADISSEUR, R., LUTTERI, L., KRZESINSKI, J.-M., CAVALIER, E., & DELANAYE, P. (October 2018). Comment j'explore...Une protéinurie. Revue Médicale de Liège, 73 (10), 519-525.

NECHIFOR, I., JONAS, C., LUTTERI, L., Beckers, A., & PINTIAUX, A. (2018). Fluctuating primary ovarian insufficiency in a case of type 2 autoimmune polyendocrinopathy. In Abstract book : Gynecological endocrinology the 18th world congress.

Pirotte, M.* , Forte, F.* , Lutteri, L., WILLEMS, E., DURAN, U., Belle, L., Baron, F., BEGUIN, Y., Maquet, P., BODART, O.* , & Servais, S.*. (2018). Neuronal surface antibody-mediated encephalopathy as manifestation of chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Journal of Neuroimmunology, 323, 115-118. doi:10.1016/j.jneuroim.2018.08.003
* These authors have contributed equally to this work.

Sid, S., LUTTERI, L., BEGUIN, Y., Louis, E., Beckers, A., & VALDES SOCIN, H. G. (2015). Familial thyrogastric autoimmune syndrome : a study of 22 kindreds. In Abstract book - 20th Annual Congress of the Belgian Society of Internal Medicine.

VALDES SOCIN, H. G., MESUREUR, T., POLUS, M., DELWAIDE, J., Louis, E., LUTTERI, L., & Beckers, A. (2015). Syndrome thyrogastrique autoimmun (STGA) : la gastrite auto-immune isolée (GAI) et celle associée à Helicobacter (Hp) ont des caractéristiques anatomocliniques différentes. In Abstract book - Annales d'Endocrinologie - 32ème Congrès de la Société Française d'Endocrinologie.

DE SENY, D., COBRAIVILLE, G., CHARLIER, E., NEUVILLE, S., LUTTERI, L., LE GOFF, C., MALAISE, D., MALAISE, O., CHAPELLE, J.-P., RELIC, B., & MALAISE, M. (2015). Apolipoprotein-A1 as a damage-associated molecular patterns protein in osteoarthritis: ex vivo and in vitro pro-inflammatory properties. PLoS ONE. doi:10.1371/journal.pone.0122904

LUTTERI, L., PESSER, M., WATRIN, P., & CAVALIER, E. (March 2014). ANTI-NUCLEAR ANTIBODIES : PREVALENCE OF DIFFERENT PATTERNS AND ANTIBODIES IN A BELGIAN UNIVERSITY LABORATORY [Poster presentation]. 9ème congrès international d’auto-immunité, Nice, France.

LUTTERI, L., PESSER, M., WATRIN, P., & CAVALIER, E. (March 2014). A PAPERLESS AUTOIMMUNITY LABORATORY : IS IT POSSIBLE ? [Poster presentation]. 9ème congrès international d’auto-immunité.

Sepulchre, E., LUTTERI, L., CAVALIER, E., Guerci, B., & RADERMECKER, R. (2014). A propos de l'hémoglobine glyquée: Les limites de son interprétation. Revue Médicale de Liège, 69 (9), 497-503.

DELANAYE, P., CAVALIER, E., Moranne, O., LUTTERI, L., KRZESINSKI, J.-M., & Bruyère, O. (12 March 2013). Creatinine - or cystatin C - based equations to estimate glomerular filtration in the general population: impact on the epidemiology of chronic kidney disease. BMC Nephrology, 14, 57. doi:10.1186/1471-2369-14-57

VALDES SOCIN, H. G., LUTTERI, L., CAVALIER, E., POLUS, M., LOUIS, E., & BECKERS, A. (2013). le syndrome auto-immun thyrogastrique: ses effets sur les micronutriments et la tumorigénèse gastrique. Revue Médicale de Liège.

HAMDI, E., DELANAYE, P., LUTTERI, L., CHAPELLE, J.-P., & CAVALIER, E. (18 July 2012). analytical and Clinical Validation of Beta-Trace Protein, a New Marker of Glomerular Filtration Rate [Poster presentation]. AACC 2012, Los Angeles, United States.

Kaux, J.-F., Le Goff, C., Renouf, J., Lutteri, L., Peters, P., Gothot, A., & Crielaard, J.-M. (October 2011). Comparison of the platelet concentrations obtained in platelet-rich plasma (PRP) between the GPS™ II and GPS™ III systems. Pathologie Biologie, 59 (5), 275-277. doi:10.1016/j.patbio.2010.11.002

TOME GARCIA, M., VALDES SOCIN, H. G., LUTTERI, L., BETEA, D., VROONEN, L., PETROSSIANS, P., Geenen, V., Louis, E., & Beckers, A. (2011). The Thyro-gastric syndrome : its prevalence, clinical, pathological and predictive factors in a prospective series of 360 patients with Hashimoto's Thyroiditis. In Abstract book - 21st Meeting of the Belgian Endocrine Society.

VALDES SOCIN, H. G., Tome, M., LUTTERI, L., Louis, E., & Beckers, A. (2011). Prevalence and prediction of gastric mucosal abnormalities in a prospective series of 50 patients with graves-Basedow disease [Poster presentation]. Belgian Internal Medicine Society, Bruxelles, Belgium.

Kaux, J.-F., Le Goff, C., Renouf, J., Peters, P., Lutteri, L., Gothot, A., & Crielaard, J.-M. (20 March 2010). GPS™ II and GPS™ III: comparison of obtained platelets concentrations [Poster presentation]. VVS Biennial Congress for Sports Medicine and Sports Sciences, Brugge, Belgium.

Delanaye, P., Cavalier, E., Saint-Remy, A., Lutteri, L., & Krzesinski, J.-M. (2009). Discrepancies between creatinine-based and cystatin C-based equations in estimating prevalence of stage 3 chronic kidney disease in an elderly population. Scandinavian Journal of Clinical and Laboratory Investigation, 69 (3), 344-9. doi:10.1080/00365510802609856

Mistretta, V., Cavalier, E., Collette, J., Lutteri, L., & Chapelle, J.-P. (2009). Intérêt des anticorps monoclonaux dans le laboratoire d'analyses biomédicales. Revue Médicale de Liège, 64 (5-6), 257-263.

Cavalier, E., Péroni, L., Abshoff, C., Lutteri, L., Chapelle, J.-P., Krzesinski, J.-M., & Delanaye, P. (November 2008). Etude analytique des trois trousses de cystatine C et impact sur les formules basées sur la cystatine pour l'estimation du DFG. Néphrologie et Thérapeutique, 4 (6), 399-400.

Delanaye, P., Cavalier, E., Saint-Remy, A., Lutteri, L., Chapelle, J.-P., & Krzesinski, J.-M. (2008). Prévalence de la maladie rénale chronique par l’estimation du DFG avec une formule basée sur la créatinine versus la cystatine C [Poster presentation]. 10ème réunion commune de la société de Néphrologie et de la société Francophone de Dialyse, Marrakech, Morocco.

Delanaye, P., Pieroni, L., Abshoff, C., Lutteri, L., Chapelle, J.-P., Krzesinski, J.-M., Hainque, B., & Cavalier, E. (2008). Analytical study of three cystatin C assays and their impact on cystatin C-based GFR-prediction equations. Clinica Chimica Acta, 398 (1-2), 118-24. doi:10.1016/j.cca.2008.09.001

Le Goff, C., Kaux, J.-F., Chapelle, J.-P., & Lutteri, L. (January 2008). Comment j'explore... Revue des principaux auto-anticorps. Revue Médicale de Liège, 63 (1), 43-9.

Meuwis, M.-A.* , Fillet, M.* , Lutteri, L., Marée, R., Geurts, P., De Seny, D., Malaise, M., Chapelle, J.-P., Wehenkel, L., Belaiche, J., Merville, M.-P., & Louis, E. (2008). Proteomics for prediction and characterization of response to infliximab in Crohn's disease: a pilot study. Clinical Biochemistry, 41 (12), 960-7. doi:10.1016/j.clinbiochem.2008.04.021
* These authors have contributed equally to this work.

Piéroni, L., Delanaye, P., Abshoff, C., Lutteri, L., Chapelle, J.-P., Hainque, B., Krzesinski, J.-M., & Cavalier, E. (2008). Impact de la stabilité de la cystatine C sur la validité des mesures dans les études rétrospectives [Poster presentation]. 10ème réunion commune de la société de Néphrologie et de la société Francophone de Dialyse, Marrakech, Morocco.

De Seny, D.* , Fillet, M.* , Meuwis, M.-A., Geurts, P., Lutteri, L., Ribbens, C., Bours, V., Wehenkel, L., Piette, J., Malaise, M., & Merville, M.-P. (2005). Discovery of new rheumatoid arthritis biomarkers using the surface-enhanced laser desorption/ionization time-of-flight mass spectrometry ProteinChip approach. Arthritis and Rheumatism, 52 (12), 3801-12. doi:10.1002/art.21607
* These authors have contributed equally to this work.

Chapelle, J.-P., Legrand, V., Lutteri, L., & Gielen, J. (2001). Cardiac troponin I and T concentrations are related to plasma lipoprotein (a) levels in PTCA patients. European Heart Journal, 22, 209.

Lutteri, L., Legrand, V., Gielen, J., & Chapelle, J.-P. (2001). Relationship between lipoprotein (a) and cardiac troponins in PTCA patients. Acta Clinica Belgica, 56, 325.

Lutteri, L., Legrand, V., Gielen, J., & Chapelle, J.-P. (2001). Association between lipoprotein (A) and cardiac troponins in PTCA patients. Clinical Chemistry and Laboratory Medicine, 39 (suppl), 278.

Chapelle, J.-P., Gielen, J., Legrand, V., & Lutteri, L. (1999). Determination of total homocysteine in plasma by automated fluorescence polarization immunoassay. Clinical Chemistry and Laboratory Medicine, 37 (suppl), 373.

Chapelle, J.-P., Lutteri, L., & Gielen, J. (1999). Evaluation of the homocysteine assay on the Abbott IMx. Clinical Chemistry, 45 (6), 134.

Lutteri, L., Chapelle, J.-P., & Gielen, J. (1999). An association demonstrated between homocysteine, CRP and troponin levels in PTCA patients. Acta Clinica Belgica. Supplementum, (suppl.1), 15.